Products & ReviewClinical Diagnostics

Accula™ Test System

Sample-to-answer nucleic acid PCR amplification platform solution for POC.

Mesa Biotech

The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our  Product Directory.

Average Rating 5.0

|2Scientists have reviewed this product

Ease of Use
After Sales Service
Value for Money
Write your own review

Great results . Easy to use

 

Average Rating 5.0

Application Area:

SARS-CoV-2 Testing

Easy to use. Great results. Great service care.

Review Date: 28 Sept 2022 | Mesa Biotech

Good equipment

 

Average Rating 5.0

Application Area:

PCR test

Easy to use for rapid Covid PCR. Sometime it’s not clear the line to read the test and some test don’t show the control line and need to repeat the test

Review Date: 21 Apr 2022 | Mesa Biotech

The Accula™ System is a sample-to-answer nucleic acid PCR amplification platform solution for the point-of-care (POC) with the simplicity, convenience and procedural familiarity of traditional rapid immunoassays. This patented system provides actionable, laboratory-quality results at POC with the sensitivity and specificity needed for infectious disease rapid immunoassay tests.

Accula Dock

The palm-size, bench top Accula Dock controls reaction temperatures, timing and fluid movements within the Accula Test Cassettes, resulting in a sample-to-answer, automated assay.

Accula Flu A/Flu B Test Cassette

The Accula Flu A/B Test is a sample-to-answer molecular diagnostic test utilizing polymerase chain reaction (PCR) technology providing results for early diagnosis and proper management of influenza

Accula RSV Test Cassette

The Accula RSV Test is a sample-to-answer molecular diagnostic test utilizing polymerase chain reaction (PCR) technology that provides results for early diagnosis and proper management of respiratory syncytial virus (RSV)

The Accula Flu A/Flu B and the Accula RSV tests have obtained CE Mark in the EU and 510(k) clearance and Clinical Laboratory Improvements Amendments (CLIA) waiver from the US Food and Drug Administration (FDA).

Product Overview

Links